The catalytic core of γ-secretase: Presenilin revisited

Current Alzheimer Research

Volumn 5, Issue 2, 2008, Pages 147-157

  Steiner, Harald ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

secretase; Alzheimer's disease; Amyloid peptide; Presenilin

Indexed keywords

AMINO ACID; AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; NOTCH RECEPTOR; PRESENILIN; PRESENILIN 1; PRESENILIN 2; PROTEINASE;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; ENZYME ACTIVITY; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PROTEIN TRANSPORT; REVIEW; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; BINDING SITES; CATALYSIS; HUMANS; MOLECULAR SEQUENCE DATA; PRESENILINS; RECEPTORS, NOTCH; SUBSTRATE SPECIFICITY;

EID: 42149182981     PISSN: 15672050     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720508783954677     Document Type: Review

References (167)

1. Haass C and Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide. Nat Rev Mol Cell Biol 8: 101-112 (2007).
2. Haass C. Take five - BACE and the γ-secretase quartet conduct Alzheimer's amyloid β-peptide generation. EMBO J 23: 483-488 (2004).
3. Reinhard C, Hebert SS and De Strooper B. The amyloid-β precursor protein: integrating structure with biological function. EMBO J 24: 3996-4006 (2005).
4. Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N and Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with endspecific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13: 45-53 (1994).
5. Laferla FM, Green KN and Oddo S. Intracellular amyloid-β in Alzheimer's disease. Nat Rev Neurosci 8: 499-509 (2007).
6. Wilson CA, Doms RW, Zheng H and Lee VM. Presenilins are not required for Aβ42 production in the early secretory pathway. Nat Neurosci 5: 849-855 (2002).
7. Lai MT, Crouthamel MC, DiMuzio J, Pietrak BL, Donoviel DB and Bernstein A. A presenilin-independent aspartyl protease prefers the γ-42 site cleavage. J Neurochem 96: 118-125 (2006).
8. Suzuki N, Cheung TT, Cai XD, Odaka A, Otvos L Jr., Eckman C, et al. An increased percentage of long amyloid β-protein secreted by familial amyloid β-protein precursor (βAPP717) mutants. Science 264: 1336-1340 (1994).
9. Ancolio K, Dumanchin C, Barelli H, Warter JM, Brice A, Campion D, et al. Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val-715 - > Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease. Proc Natl Acad Sci USA 96: 4119-4124. (1999).
10. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, et al. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production. Nature 360: 672-674 (1992).
11. Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286: 735-741 (1999).
12. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, et al. BACE1 is the major β-secretase for generation of Aβ peptides by neurons. Nat Neurosci 4: 233-234 (2001).
13. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-Khan S, Denis P, et al. Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation. Nat Neurosci 4: 231-232 (2001).
14. Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, et al. Control of peripheral nerve myelination by the β-secretase BACE1. Science 314: 664-666 (2006).
15. Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci 9: 1520-1525 (2006).
16. Edbauer D, Winkler E, Regula JT, Pesold B, Steiner H and Haass C. Reconstitution of γ-secretase activity. Nat Cell Biol 5: 486-488 (2003).
17. Kimberly WT, LaVoie MJ, Ostaszewski BL, Ye W, Wolfe MS and Selkoe DJ. γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, Aph-1, and Pen-2. Proc Natl Acad Sci USA 100: 6382-6387 (2003).
18. Takasugi N, Tomita T, Hayashi I, Tsuruoka M, Niimura M, Takahashi Y, et al. The role of presenilin cofactors in the γ-secretase complex. Nature 422: 438-441 (2003).
19. Hebert SS, Serneels L, Dejaegere T, Horre K, Dabrowski M, Baert V, et al. Coordinated and widespread expression of γ-secretase in vivo: evidence for size and molecular heterogeneity. Neurobiol Dis 17: 260-272 (2004).
20. Shirotani K, Edbauer D, Prokop S, Haass C and Steiner H. Identification of distinct γ-secretase complexes with different APH-1 variants. J Biol Chem 279: 41340-41345 (2004).
21. Vetrivel KS, Zhang YW, Xu H and Thinakaran G. Pathological and physiological functions of presenilins. Mol Neurodegener 1: 4 (2006).
22. Parks AL and Curtis D. Presenilin diversifies its portfolio. Trends Genet 23: 140-150 (2007).
23. Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375: 754-760 (1995).
24. Rogaev EI, Sherrington R, Rogaeva EA, Levesque G, Ikeda M, Liang Y, et al. Familial Alzheimer's disease in kindreds with mis sense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 376: 775-778. (1995).
25. Levy-Lahad E, Wasco W, Poorkaj P, Romano DM, Oshima J, Pettingell WH, et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 269: 973-977. (1995).
26. Oh YS and Turner RJ. Evidence that the COOH terminus of human presenilin 1 is located in extracytoplasmic space. Am J Physiol Cell Physiol 289: C576-581 (2005).
27. Henricson A, Kall L and Sonnhammer EL. A novel transmembrane topology of presenilin based on reconciling experimental and computational evidence. FEBS J 272: 2727-2733 (2005).
28. Laudon H, Hansson EM, Melen K, Bergman A, Farmery MR, Winblad B, et al. A nine-transmembrane domain topology for presenilin 1. J Biol Chem 280: 35352-35360 (2005)
29. Spasic D, Tolia A, Dillen K, Baert V, De Strooper B, Vrijens S, et al. Presenilin-1 maintains a nine-transmembrane topology throughout the secretory pathway. J Biol Chem 281: 26569-26577 (2006).
30. Thinakaran G, Borchelt DR, Lee MK, Slunt HH, Spitzer L, Kim G, et al. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo. Neuron 17: 181-190 (1996).
31. Scheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, et al. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2: 864-870 (1996).
32. Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, et al. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Aβ42 production. Proc Natl Acad Sci USA 99: 8025-8030 (2002).
33. Bentahir M, Nyabi O, Verhamme J, Tolia A, Horre K, Wiltfang J, et al. Presenilin clinical mutations can affect γ-secretase activity by different mechanisms. J Neurochem 96: 732-742 (2006).
34. Kumar-Singh S, Theuns J, Van Broeck B, Pirici D, Vennekens K, Corsmit E, et al. Mean age-of-onset of familial Alzheimer disease caused by presenilin mutations correlates with both increased Aβ42 and decreased Aβ40. Hum Mutat 27: 686-695 (2006).
35. Duering M, Grimm MO, Grimm HS, Schroder J and Hartmann T. Mean age of onset in familial Alzheimer's disease is determined by amyloid β 42. Neurobiol Aging 26: 785-788 (2005).
36. Walker ES, Martinez M, Brunkan AL and Goate A. Presenilin 2 familial Alzheimer's disease mutations result in partial loss of function and dramatic changes in Aβ42/40 ratios. J Neurochem 92: 294-301 (2005).
37. Lee MK, Slunt HH, Martin LJ, Thinakaran G, Kim G, Gandy SE, et al. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J Neurosci 16: 7513-7525 (1996).
38. Lai MT, Chen E, Crouthamel MC, DiMuzio-Mower J, Xu M, Huang Q, et al. Presenilin-1 and presenilin-2 exhibit distinct yet overlapping γ-secretase activities. J Biol Chem 278: 22475-22481 (2003).
39. Levitan D and Greenwald I. Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. Nature 377: 351-354 (1995).
40. Wong PC, Zheng H, Chen H, Becher MW, Sirinathsinghji DJ, Trumbauer ME, et al. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 387: 288-292 (1997).
41. Shen J, Bronson RT, Chen DF, Xia W, Selkoe DJ and Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 89: 629-639 (1997).
42. De Strooper B, Saftig P, Craessaerts K, Vanderstichele H, Guhde G, Annaert W, et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391: 387-390 (1998).
43. Naruse S, Thinakaran G, Luo JJ, Kusiak JW, Tomita T, Iwatsubo T, et al. Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21: 1213-1221 (1998).
44. Schroeter EH, Kisslinger JA and Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393: 382-386 (1998).
45. Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, et al. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell 5: 207-216 (2000).
46. Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, et al. A ligand-induced extracellular cleavage regulates γ-secretase-like proteolytic activation of Notch1. Mol Cell 5: 197-206 (2000).
47. Struhl G and Adachi A. Nuclear access and action of Notch in vivo. Cell 93: 649-660 (1998).
48. Struhl G and Greenwald I. Presenilin is required for activity and nuclear access of Notch in Drosophila. Nature 398: 522-525 (1999).
49. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, et al. A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain. Nature 398: 518-522 (1999).
50. Herreman A, Serneels L, Annaert W, Collen D, Schoonjans L and De Strooper B. Total inactivation of γ-secretase activity in presenilin-deficient embryonic stem cells. Nat Cell Biol 2: 461-462 (2000).
51. Zhang Z, Nadeau P, Song W, Donoviel D, Yuan M, Bernstein A, et al. Presenilins are required for γ-secretase cleavage of βAPP and transmembrane cleavage of Notch-1. Nat Cell Biol 2: 463-465 (2000).
52. Murphy MP, Hickman LJ, Eckman CB, Uljon SN, Wang R and Golde TE. γ-Secretase, evidence for multiple proteolytic activities and influence of membrane positioning of substrate on generation of amyloid β peptides of varying length. J Biol Chem 274: 11914-11923 (1999).
53. Wolfe MS, Citron M, Diehl TS, Xia W, Donkor IO and Selkoe DJ. A substrate-based difluoro ketone selectively inhibits Alzheimer's γ-secretase activity. J Med Chem 41: 6-9 (1998).
54. Wolfe MS, Xia W, Moore CL, Leatherwood DD, Ostaszewski B, Rahmati T, et al. Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry 38: 4720-4727 (1999).
55. Shearman MS, Beher D, Clarke EE, Lewis HD, Harrison T, Hunt P, et al. L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid β-protein precursor γ-secretase activity. Biochemistry 39: 8698-8704 (2000).
56. Li YM, Lai MT, Xu M, Huang Q, DiMuzio-Mower J, Sardana MK, et al. Presenilin 1 is linked with γ-secretase activity in the detergent solubilized state. Proc Natl Acad Sci U.S.A. 97: 6138-6143 (2000).
57. Wolfe MS, Xia W, Ostaszewski BL, Diehl TS, Kimberly WT and Selkoe DJ. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398: 513-517 (1999).
58. Steiner H, Duff K, Capell A, Romig H, Grim MG, Lincoln S, et al. A loss of function mutation of presenilin-2 interferes with amyloid β-peptide production and Notch signaling. J Biol Chem 274: 28669-28673 (1999).
59. Kimberly WT, Xia W, Rahmati T, Wolfe MS and Selkoe DJ. The transmembrane aspartates in presenilin 1 and 2 are obligatory for γ-secretase activity and amyloid β-protein generation. J Biol Chem 275: 3173-3178 (2000).
60. Leimer U, Lun K, Romig H, Walter J, Grünberg J, Brand M, et al. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid β-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 38: 13602-13609 (1999).
61. Esler WP, Kimberly WT, Ostaszewski BL, Diehl TS, Moore CL, Tsai J-Y, et al. Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1. Nat Cell Biol 2: 428-433 (2000).
62. Li YM, Xu M, Lai MT, Huang Q, Castro JL, DiMuzio-Mower J, et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405: 689-694 (2000).
63. Seiffert D, Bradley JD, Rominger CM, Rominger DH, Yang F, Meredith JE, Jr., et al. Presenilin-1 and -2 are molecular targets for γ-secretase inhibitors. J Biol Chem 275: 34086-34091 (2000).
64. Vassar R. The β-secretase, BACE. A prime target for Alzheimer's disease. J Mol Neurosci 17: 157-170 (2001).
65. Steiner H, Kostka M, Romig H, Basset G, Pesold B, Hardy J, et al. Glycine 384 is required for presenilin-1 function and is conserved in polytopic bacterial aspartyl proteases. Nat Cell Biol 2: 848-851 (2000).
66. LaPointe CF and Taylor RK. The type 4 prepilin peptidases comprise a novel family of aspartic acid proteases. J Biol Chem 275: 1502-1510 (2000).
67. Weihofen A, Binns K, Lemberg MK, Ashman K and Martoglio B. Identification of signal peptide peptidase, a presenilin-type aspartic protease. Science 296: 2215-2218 (2002).
68. Friedmann E, Hauben E, Maylandt K, Schleeger S, Vreugde S, Lichtenthaler SF, et al. SPPL2a and SPPL2b promote intramembrane proteolysis of TNFα in activated dendritic cells to trigger IL-12 production. Nat Cell Biol 8: 843-848 (2006).
69. Fluhrer R, Grammer G, Israel L, Condron MM, Haffner C, Friedmann E, et al. A γ-secretase-like intramembrane cleavage of TNFα by the GxGD aspartyl protease SPPL2b. Nat Cell Biol 8: 894-896 (2006).
70. Ponting CP, Hutton M, Nyborg A, Baker M, Jansen K and Golde TE. Identification of a novel family of presenilin homologues. Hum Mol Genet 11: 1037-1044 (2002).
71. Grigorenko AP, Moliaka YK, Korovaitseva GI and Rogaev EI. Novel class of polytopic proteins with domains associated with putative protease activity. Biochemistry (Mosc) 67: 826-835 (2002).
72. Friedmann E, Lemberg MK, Weihofen A, Dev KK, Dengler U, Rovelli G, et al. Consensus analysis of signal peptide peptidase and homologous human aspartic proteases reveals opposite topology of catalytic domains compared with presenilins. J Biol Chem 279: 50790-50798 (2004).
73. Wolfe MS and Kopan R. Intramembrane proteolysis: theme and variations. Science 305: 1119-1123 (2004).
74. Capell A, Steiner H, Romig H, Keck S, Baader M, Grim MG, et al. Presenilin-1 differentially facilitates endoproteolysis of the β-amyloid precursor protein and Notch. Nat Cell Biol 2: 205-211 (2000).
75. Morihara T, Katayama T, Sato N, Yoneda T, Manabe T, Hitomi J, et al. Absence of endoproteolysis but no effects on amyloid β production by alternative splicing forms of presenilin-1, which lack exon 8 and replace D257A. Brain Res Mol Brain Res 85: 85-90. (2000).
76. Kim SH, Leem JY, Lah JJ, Slunt HH, Levey AI, Thinakaran G, et al. Multiple effects of aspartate mutant presenilin 1 on the processing and trafficking of amyloid precursor protein. J Biol Chem 276: 43343-43350. (2001).
77. Nyabi O, Bentahir M, Horre K, Herreman A, Gottardi-Littell N, Van Broeckhoven C, et al. Presenilins mutated at Asp257 or Asp385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem 278: 43430-43436 (2003).
78. Weidemann A, Eggert S, Reinhard FB, Vogel M, Paliga K, Baier G, et al. A novel ε-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41: 2825-2835 (2002).
79. Sastre M, Steiner H, Fuchs K, Capell A, Multhaup G, Condron MM, et al. Presenilin-dependent γ-secretase processing of β-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep 2: 835-841 (2001).
80. Gu Y, Misonou H, Sato T, Dohmae N, Takio K and Ihara Y. Distinct intramembrane cleavage of the β-amyloid precursor protein family resembling γ-secretase-like cleavage of Notch. J Biol Chem 276: 35235-35238. (2001).
81. Yu C, Kim SH, Ikeuchi T, Xu H, Gasparini L, Wang R, et al. Characterization of a presenilin-mediated APP carboxyl terminal fragment γ: evidence for distinct mechanisms involved in γ-secretase processing of the APP and Notch1 transmembrane domains. J Biol Chem 276: 43756-43760 (2001).
82. Okochi M, Steiner H, Fukumori A, Tanii H, Tomita T, Tanaka T, et al. Presenilins mediate a dual intramembraneous γ-secretase cleavage of Notch-1. EMBO J 21: 5408-5416 (2002).
83. Berezovska O, Jack C, McLean P, Aster JC, Hicks C, Xia W, et al. Aspartate mutations in presenilin and γ-secretase inhibitors both impair notch1 proteolysis and nuclear translocation with relative preservation of notch1 signaling. J Neurochem 75: 583-593. (2000).
84. Hadland B, Manley N, Su DM, Longmore G, Moore C, Wolfe M, et al. γ-Secretase inhibitors repress thymocyte development. Proc Natl Acad Sci USA 98: 7487-7491 (2001).
85. Geling A, Steiner H, Willem M and Bally-Cuif L, Haass C. A γ-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep 3: 688-694 (2002).
86. Thinakaran G, Harris CL, Ratovitski T, Davenport F, Slunt HH, Price DL, et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J Biol Chem 272: 28415-28422 (1997).
87. Seeger M, Nordstedt C, Petanceska S, Kovacs DM, Gouras GK, Hahne S, et al. Evidence for phosphorylation and oligomeric assembly of presenilin 1. Proc Natl Acad Sci USA 94: 5090-5094 (1997).
88. Capell A, Grünberg J, Pesold B, Diehlmann A, Citron M, Nixon R, et al. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100-150-kDa molecular mass complex. J Biol Chem 273: 3205-3211 (1998).
89. Thinakaran G, Regard JB, Bouton CM, Harris CL, Price DL, Borchelt DR, et al. Stable association of presenilin derivatives and absence of presenilin interactions with APP Neurobiol Dis 4: 438-453 (1998).
90. Yu G, Chen F, Levesque G, Nishimura M, Zhang DM, Levesque L, et al. The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains β-catenin. J Biol Chem 273: 16470-16475 (1998).
91. Citron M, Westaway D, Xia W, Carlson G, Diehl T, Levesque G, et al. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice. Nat Med 3: 67-72 (1997).
92. Steiner H. Uncovering γ-secretase. Curr Alzheimer Res 1: 175-181 (2004).
93. Iwatsubo T. The γ-secretase complex: machinery for intramembrane proteolysis. Curr Opin Neurobiol 14: 379-383 (2004).
94. Prokop S, Shirotani K, Edbauer D, Haass C and Steiner H. Requirement of PEN-2 for stabilization of the presenilin NTF/CTF heterodimer within the γ-secretase complex. J Biol Chem 279: 23255-23261 (2004).
95. Shah S, Lee SF, Tabuchi K, Hao YH, Yu C, LaPlant Q, et al. Nicastrin functions as a γ-secretase-substrate receptor. Cell 122: 435-447 (2005).
96. Kaether C, Lammich S, Edbauer D, Ertl M, Rietdorf J, Capell A, et al. A presenilin-1/nicastrin complex is targeted to the plasma membrane and affects trafficking and processing of the β-amyloid precursor protein. J Cell Biol 158: 551-561 (2002).
97. Pasternak SH, Bagshaw RD, Guiral M, Zhang S, Ackerley CA, Pak BJ, et al. Presenilin-1, nicastrin, APP and γ-secretase activity are co-localized in the lysosomal membrane. J Biol Chem (2003).
98. Chyung JH, Raper DM and Selkoe DJ. γ-Secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage. J Biol Chem 280: 4383-4392 (2005).
99. Hansson EM, Stromberg K, Bergstedt S, Yu G, Naslund J, Lundkvist J, et al. Aph-1 interacts at the cell surface with proteins in the active γ-secretase complex and membrane-tethered Notch. J Neurochem 92: 1010-1020 (2005).
100. Kaether C, Schmitt S, Willem M and Haass C. Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 7: 408-415 (2006).
101. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, et al. Presenilin 1 controls γ-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 147: 277-294 (1999).
102. Cupers P, Bentahir M, Craessaerts K, Orlans I, Vanderstichele H, Saftig P, et al. The discrepancy between presenilin subcellular localization and γ-secretase processing of amyloid precursor protein. J Cell Biol 154: 731-740 (2001).
103. Steiner H, Romig H, Grim MG, Philipp U, Pesold B, Citron M, et al. The biological and pathological function of the presenilin-1 Δexon 9 mutation is independent of its defect to undergo proteolytic processing. J Biol Chem 274: 7615-7618 (1999).
104. Podlisny MB, Citron M, Amarante P, Sherrington R, Xia W, Zhang J, et al. Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis 3: 325-337 (1997).
105. Steiner H, Romig H, Pesold B, Philipp U, Baader M, Citron M, et al. Amyloidogenic function of the Alzheimer's disease-associated presenilin 1 in the absence of endoproteolysis. Biochemistry 38: 14600-14605 (1999).
106. Jacobsen H, Reinhardt D, Brockhaus M, Bur D, Kocyba C, Kurt H, et al. The influence of endoproteolytic processing of familial Alzheimer's disease presenilin 2 on Aβ42 amyloid peptide formation. J Biol Chem 274: 35233-35239 (1999).
107. Shirotani K, Takahashi K, Araki W, Maruyama K and Tabira T. Mutational analysis of intrinsic regions of presenilin 2 that determine its endoproteolytic cleavage and pathological function. J Biol Chem 275: 3681-3686 (2000).
108. Laudon H, Karlstrom H, Mathews PM, Farmery MR, Gandy SE, Lundkvist J, et al. Functional domains in presenilin 1: the Tyr-288 residue controls γ-secretase activity and endoproteolysis. J Biol Chem 279: 23925-23932 (2004).
109. Wang J, Brunkan AL, Hecimovic S, Walker E and Goate A. Conserved "PAL" sequence in presenilins is essential for γ-secretase activity, but not required for formation or stabilization of γ-secretase complexes. Neurobiol Dis 15: 654-666 (2004).
110. Nakaya Y, Yamane T, Shiraishi H, Wang HQ, Matsubara E, Sato T, et al. Random mutagenesis of presenilin-1 identifies novel mutants exclusively generating long amyloid β-peptides. J Biol Chem 280: 19070-19077 (2005).
111. Brunkan AL, Martinez M, Walker ES and Goate AM. Presenilin endoproteolysis is an intramolecular cleavage. Mol Cell Neurosci 29: 65-73 (2005).
112. Beher D, Wrigley JD, Nadin A, Evin G, Masters CL, Harrison T, et al. Pharmacological knock-down of the presenilin 1 heterodimer by a novel γ-secretase inhibitor: implications for presenilin biology. J Biol Chem 276: 45394-45402 (2001).
113. Campbell WA, Iskandar MK, Reed ML and Xia W. Endoproteolysis of presenilin in vitro: inhibition by γ-secretase inhibitors. Biochemistry 41: 3372-3379 (2002).
114. Campbell WA, Reed ML, Strahle J, Wolfe MS and Xia W. Presenilin endoproteolysis mediated by an aspartyl protease activity pharmacologically distinct from γ-secretase. J Neurochem 85: 1563-1574 (2003).
115. Tolia A, Chavez-Gutierrez L and De Strooper B. Contribution of presenilin transmembrane domains 6 and 7 to a water-containing cavity in the γ-secretase complex. J Biol Chem 281: 27633-27642 (2006).
116. Sato C, Morohashi Y, Tomita T and Iwatsubo T. Structure of the catalytic pore of γ-secretase probed by the accessibility of substituted cysteines. J Neurosci 26: 12081-12088 (2006).
117. Wrigley JD, Nunn EJ, Nyabi O, Clarke EE, Hunt P, Nadin A, et al. Conserved residues within the putative active site of γ-secretase differentially influence enzyme activity and inhibitor binding. J Neurochem 90: 1312-1320 (2004).
118. Wang J, Beher D, Nyborg AC, Shearman MS, Golde TE and Goate A. C-terminal PAL motif of presenilin and presenilin homologues required for normal active site conformation. J Neurochem 96: 218-227 (2006).
119. Dovey HF, John V, Anderson JP, Chen LZ, de Saint Andrieu P, Fang LY, et al. Functional γ-secretase inhibitors reduce β-amyloid peptide levels in brain. J Neurochem 76: 173-181 (2001).
120. Lazarov VK, Fraering PC, Ye W, Wolfe MS, Selkoe DJ and Li H. Electron microscopic structure of purified, active γ-secretase reveals an aqueous intramembrane chamber and two pores. Proc Natl Acad Sci USA 103: 6889-6894 (2006).
121. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK and Rosenfeld MG. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-κB and β-amyloid precursor protein. Cell 110: 55-67 (2002).
122. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, et al. Presenilin-dependent transcriptional control of the Aβ-degrading enzyme neprilysin by intracellular domains of βAPP and APLP. Neuron 46: 541-554 (2005).
123. Von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci 117: 4435-4448 (2004).
124. Cao X and Südhof TC. A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293: 115-120. (2001).
125. Hebert SS, Serneels L, Tolia A, Craessaerts K, Derks C, Filippov MA, et al. Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep 7: 739-745 (2006).
126. Zhang YW, Wang R, Liu Q, Zhang H, Liao FF and Xu H. Presenilin/γ- secretase-dependent processing of β-amyloid precursor protein regulates EGF receptor expression. Proc Natl Acad Sci USA 104: 10613-10618 (2007).
127. Kopan R and Ilagan MX. γ-Secretase: proteasome of the membrane? Nat Rev Mol Cell Biol 5: 499-504 (2004).
128. Ma G, Li T, Price DL and Wong PC. APH-1a is the principal mammalian APH-1 isoform present in γ-secretase complexes during embryonic development. J Neurosci 25: 192-198 (2005).
129. Serneels L, Dejaegere T, Craessaerts K, Horre K, Jorissen E, Tousseyn T, et al. Differential contribution of the three Aph1 genes to γ-secretase activity in vivo. Proc Natl Acad Sci USA 102: 1719-1724 (2005).
130. Coolen MW, Van Loo KM, van Bakel NN, Ellenbroek BA, Cools AR and Martens GJ. Reduced Aph-1b expression causes tissueand substrate-specific changes in γ-secretase activity in rats with a complex phenotype. FASEB J 20: 175-177 (2006).
131. Shirotani K, Tomioka M, Kremmer E, Haass C and Steiner H. Pathological activity of familial Alzheimer's disease-associated mutant presenilin can be executed by six different γ-secretase complexes. Neurobiol Dis 27: 102-107 (2007).
132. Mastrangelo P, Mathews PM, Chishti MA, Schmidt SD, Gu Y, Yang J, et al. Dissociated phenotypes in presenilin transgenic mice define functionally distinct γ-secretases. Proc Natl Acad Sci USA 102: 8972-8977 (2005).
133. Struhl G and Adachi A. Requirements for presenilin-dependent cleavage of Notch and other transmembrane proteins. Mol Cell 6: 625-636 (2000).
134. Esler WP, Kimberly WT, Ostaszewski BL, Ye W, Diehl TS, Selkoe DJ, et al. Activity-dependent isolation of the presenilin-γ-secretase complex reveals nicastrin and a γ substrate. Proc Natl Acad Sci USA 99: 2720-2725. (2002).
135. Tian G, Sobotka-Briner CD, Zysk J, Liu X, Birr C, Sylvester MA, et al. Linear non-competitive inhibition of solubilized human γ-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines. J Biol Chem 277: 31499-31505 (2002).
136. Tian G, Ghanekar SV, Aharony D, Shenvi AB, Jacobs RT, Liu X, et al. The mechanism of γ-secretase: multiple inhibitor binding sites for transition state analogs and small molecule inhibitors. J Biol Chem 278: 28968-28975 (2003).
137. Kornilova AY, Das C and Wolfe MS. Differential effects of inhibitors on the γ-secretase complex. Mechanistic implications. J Biol Chem 278: 16470-16473 (2003).
138. Kornilova AY, Bihel F, Das C and Wolfe MS. The initial substrate-binding site of γ-secretase is located on presenilin near the active site. Proc Natl Acad Sci USA 102: 3230-3235 (2005).
139. Yamasaki A, Eimer S, Okochi M, Smialowska A, Kaether C, Baumeister R, et al. The GxGD motif of presenilin contributes to catalytic function and substrate identification of γ-secretase. J Neurosci 26: 3821-3828 (2006).
140. Lammich S, Okochi M, Takeda M, Kaether C, Capell A, Zimmer AK, et al. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Aβ-like peptide. J Biol Chem 277: 44754-44759 (2002).
141. Zhao G, Mao G, Tan J, Dong Y, Cui MZ, Kim SH, et al. Identification of a new presenilin-dependent ζ-cleavage site within the transmembrane domain of amyloid precursor protein. J Biol Chem 279: 50647-50650 (2004).
142. Qi-Takahara Y, Morishima-Kawashima M, Tanimura Y, Dolios G, Hirotani N, Horikoshi Y, et al. Longer forms of amyloid β protein: implications for the mechanism of intramembrane cleavage by γ-secretase. J Neurosci 25: 436-445 (2005).
143. Chandu D, Huppert SS and Kopan R. Analysis of transmembrane domain mutants is consistent with sequential cleavage of Notch by γ-secretase. J Neurochem 96: 228-235 (2006).
144. Sardi SP, Murtie J, Koirala S, Patten BA and Corfas G. Presenilindependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127: 185-197 (2006).
145. Munter LM, Voigt P, Harmeier A, Kaden D, Gottschalk KE, Weise C, et al. GxxxG motifs within the amyloid precursor protein transmembrane sequence are critical for the etiology of Aβ42. EMBO J 26: 1702-1712 (2007).
146. Cervantes S, Gonzalez-Duarte R and Marfany G. Homodimerization of presenilin N-terminal fragments is affected by mutations linked to Alzheimer's disease. FEBS Lett 505: 81-86 (2001).
147. Cervantes S, Saura CA, Pomares E, Gonzalez-Duarte R and Marfany G. Functional implications of the presenilin dimerization: reconstitution of γ-secretase activity by assembly of a catalytic site at the dimer interface of two catalytically inactive presenilins. J Biol Chem 279: 36519-36529 (2004).
148. Schroeter EH, Ilagan MX, Brunkan AL, Hecimovic S, Li YM, Xu M, et al. A presenilin dimer at the core of the γ-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis. Proc Natl Acad Sci USA 100: 13075-13080 (2003).
149. Clarke EE, Churcher I, Ellis S, Wrigley JD, Lewis HD, Harrison T, et al. Intra- or intercomplex binding to the γ-secretase enzyme. A model to differentiate inhibitor classes. J Biol Chem 281: 31279-31289 (2006).
150. De Strooper B. Loss-of-function presenilin mutations in Alzheimer disease. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 8: 141-146 (2007).
151. Wolfe MS. When loss is gain: reduced presenilin proteolytic function leads to increased Aβ42/Aβ40. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep 8: 136-140 (2007).
152. Baumeister R, Leimer U, Zweckbronner I, Jakubek C, Grünberg J and Haass C. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct 1: 149-159 (1997).
153. Levitan D, Doyle TG, Brousseau D, Lee MK, Thinakaran G, Slunt HH, et al. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc Natl Acad Sci USA 93: 14940-14944 (1996).
154. Song W, Nadeau P, Yuan M, Yang X, Shen J and Yankner BA. Proteolytic release and nuclear translocation of Notch-1 are induced by presenilin-1 and impaired by pathogenic presenilin-1 mutations. Proc Natl Acad Sci USA 96: 6959-6963 (1999).
155. Chen F, Gu Y, Hasegawa H, Ruan X, Arawaka S, Fraser P, et al. Presenilin 1 mutations activate γ42-secretase but reciprocally inhibit ε-secretase cleavage of amyloid precursor protein (APP) and S3-cleavage of notch. J Biol Chem 277: 36521-36526 (2002).
156. Wiley JC, Hudson M, Kanning KC, Schecterson LC and Bothwell M. Familial Alzheimer's disease mutations inhibit γ-secretase-mediated liberation of β-amyloid precursor protein carboxy-terminal fragment. J Neurochem 94: 1189-1201 (2005).
157. Kulic L, Walter J, Multhaup G, Teplow DB, Baumeister R, Romig H, et al. Separation of presenilin function in amyloid β-peptide generation and endoproteolysis of Notch. Proc Natl Acad Sci USA 97: 5913-5918. (2000).
158. Qian S, Jiang P, Guan XM, Singh G, Trumbauer ME, Yu H, et al. Mutant human presenilin 1 protects presenilin 1 null mouse against embryonic lethality and elevates Aβ1-42/43 expression. Neuron 20: 611-617 (1998).
159. Davis JA, Naruse S, Chen H, Eckman C, Younkin S, Price DL, et al. An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos. Neuron 20: 603-609 (1998).
160. Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, et al. A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity. Nature 414: 212-216 (2001).
161. Takahashi Y, Hayashi I, Tominari Y, Rikimaru K, Morohashi Y, Kan T, et al. Sulindac sulfide is a noncompetitive γ-secretase inhibitor that preferentially reduces Aβ42 generation. J Biol Chem 278: 18664-18670 (2003).
162. Beher D, Clarke EE, Wrigley JD, Martin AC, Nadin A, Churcher I, et al. Selected non-steroidal anti-inflammatory drugs and their derivatives target γ-secretase at a novel site. Evidence for an allosteric mechanism. J Biol Chem 279: 43419-43426 (2004).
163. Edbauer D, Winkler E, Haass C and Steiner H. Presenilin and nicastrin regulate each other and determine amyloid β-peptide production via complex formation. Proc Natl Acad Sci USA 99: 8666-8671 (2002).
164. Farmery MR, Tjernberg LO, Pursglove SE, Bergman A, Winblad B and Naslund J. Partial purification and characterization of γ-secretase from post mortem human brain. J Biol Chem 278: 24277-24284 (2003).
165. Zhou S, Zhou H, Walian PJ and Jap BK. CD147 is a regulatory subunit of the γ-secretase complex in Alzheimer's disease amyloid β-peptide production. Proc Natl Acad Sci USA 102: 7499-7504 (2005).
166. Chen F, Hasegawa H, Schmitt-Ulms G, Kawarai T, Bohm C, Katayama T, et al. TMP21 is a presenilin complex component that modulates γ-secretase but not ε-secretase activity. Nature 440: 1208-1212 (2006).
167. Vetrivel KS, Gong P, Bowen JW, Cheng H, Chen Y, Carter M, et al. Dual roles of the transmembrane protein p23/TMP21 in the modulation of amyloid precursor protein metabolism. Mol Neurodegener 2: 4 (2007).